Legal & General Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Legal & General Group's MXCT Position: Q2 2026 in Review
Legal & General Group sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 8,963 shares — an estimated $6.3K sold.
Legal & General Group first reported a position in MXCT in Q3 2021 and held it in 19 quarters. The position peaked at $10.4M in Q3 2021. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Legal & General Group reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
- Legal & General Group sold 8,963 MaxCyte shares in Q2 2026, an estimated $6.3K.
- Legal & General Group first reported a position in MaxCyte in Q3 2021 and held it in 19 quarters.
- Legal & General Group's MaxCyte position peaked at $10.4M in Q3 2021.
- 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.